|
2006 Conference Publication Evaluating how guidelines for replacement therapy were implemented following withdrawal of rofecoxibBarozzi, N. and Tett, S. E. (2006). Evaluating how guidelines for replacement therapy were implemented following withdrawal of rofecoxib. The National Institute of Clinical Studies Using Evidence: Using, Melbourne, 19-20 October 2006. Melbourne: National Institute of Clinical Studies. |
|
2006 Conference Publication Spin-offs and bonanzas from Queensland participating in CAPTIONPulver, L., Coombes, J., Petrie, A. F. and Tett, S. E. (2006). Spin-offs and bonanzas from Queensland participating in CAPTION. Quality Use of Medicines: Balancing Beliefs, Benefits and Harms, Canberra / National Convention Centre, 7-9 June 2006. Canberra: National Prescribing Service Limited. |
|
2006 Conference Publication Influencing emergency department prescribing in the management of community acquired pneumonia - the CAPTION projectMaxwell, D. J., Kaye, K. I., MacIntosh, K. A., Robertson, M. B., Stanton, L. A., Peterson, G. M., Marwood, A. C., Dollman, W. B., Pulver, L., Tett, S. E., Wai, A. and Mackson, J. (2006). Influencing emergency department prescribing in the management of community acquired pneumonia - the CAPTION project. Australian Society for Antimicrobials 7th Annual Scientific Meeting, Sydney / Crowne Plaza, Coogee Beach, 23-25 February 2006. Sydney: Australian Society for Antimicrobials. |
|
2006 Conference Publication How did rofecoxib withdrawal influence overall non-steroidal anti-inflammatory drug (NSAIDs) and paracetamol prescribing in Australia?Barozzi, N. and Tett, S. E. (2006). How did rofecoxib withdrawal influence overall non-steroidal anti-inflammatory drug (NSAIDs) and paracetamol prescribing in Australia?. Quality Use of Medicines: Balancing Beliefs, Benefits and Harms, Canberra / National Convention Centre, 7-9 June 2006. Canberra: National Prescribing Service Limited. |
|
2006 Journal Article A Bayesian approach for population pharmacokinetic modelling of sirolimusDansirikul, Chantaratsamon, Morris, Raymond G., Tett, Susan E. and Duffull, Stephen B. (2006). A Bayesian approach for population pharmacokinetic modelling of sirolimus. British Journal of Clinical Pharmacology, 62 (4), 420-434. doi: 10.1111/j.1365-2125.2005.02533.x |
|
2006 Conference Publication Geographical differences in antidepressant and benzodiazepine prescribing in rural and urban QueenslandCoulson, F. R. and Tett, S. E. (2006). Geographical differences in antidepressant and benzodiazepine prescribing in rural and urban Queensland. Quality use of medicines: Balancing beliefs, benefits and harms, National Convention Centre, Canberrra, 7-9 June 2006. Brisbane: National Prescribing Service. |
|
2005 Journal Article Consumer involvement in quality use of medicines (QUM) projects - lessons from AustraliaKirkpatrick, Carl M. J., Roughead, Elizabeth E., Monteith, Gregory R. and Tett, Susan E. (2005). Consumer involvement in quality use of medicines (QUM) projects - lessons from Australia. BMC Health Services Research, 5 (1) 75, 75.1-75.7. doi: 10.1186/1472-6963-5-75 |
|
2005 Journal Article Population pharmacokinetics of mycophenolic acid during the first week after renal transplantationStaatz, Christine E., Duffull, Stephen B., Kiberd, Bryce, Fraser, Albert D. and Tett, Susan E. (2005). Population pharmacokinetics of mycophenolic acid during the first week after renal transplantation. European Journal of Clinical Pharmacology, 61 (7), 507-516. doi: 10.1007/s00228-005-0927-4 |
|
2005 Journal Article Quantifying the use of the statin antilipemic drugs: Comparisons and contrasts between Nova Scotia, Canada, and Queensland, AustraliaCooke, C., Nissen, L. M., Sketris, I. S. and Tett, S. E. (2005). Quantifying the use of the statin antilipemic drugs: Comparisons and contrasts between Nova Scotia, Canada, and Queensland, Australia. Clinical Therapeutics, 27 (4), 497-508. doi: 10.1016/j.clinthera.2005.04.009 |
|
2005 Journal Article Pharmacokinetic considerations relating to tacrolimus dosing in the elderlyStaatz, C. E. and Tett, S. E. (2005). Pharmacokinetic considerations relating to tacrolimus dosing in the elderly. Drugs & Aging, 22 (7), 541-557. doi: 10.2165/00002512-200522070-00001 |
|
2005 Conference Publication Consumers on the map: Australia's QUM mapTett, S. E., Roughead, E. E., Monteith, G. R. and Kirkpatrick, C. M. J. (2005). Consumers on the map: Australia's QUM map. The Society of Hospital Pharmacists of Australia 27th Federal Conference, Brisbane, Qld, Australia, 10-13 November, 2005. Brisbane, Qld, Australia: Event Planners Australia. |
|
2005 Conference Publication How much, how often, how long?Tett, S. E. (2005). How much, how often, how long?. Joint Meeting of ASCEPT and APSA, Melbourne, 4-7 Dec. 2005. Australia: Australasian Society of Clinical & Experimental Pharmacologists & Toxicologists. |
|
2005 Conference Publication Drug utilisation review across jurisdictions: A reality or still a distant dream?Pulver, L. and Tett, S.E. (2005). Drug utilisation review across jurisdictions: A reality or still a distant dream?. The Society of Hospital Pharmacists of Australia 27th Federal Conference, Brisbane, 10-13 Nov. 2005. Brisbane: Event Planners Australia. |
|
2005 Journal Article Relationships between sirolimus dosing, concentration and outcomes in renal transplant recipientsDansirikul, C., Duffull, S. B., Morris, R. G. and Tett, S. E. (2005). Relationships between sirolimus dosing, concentration and outcomes in renal transplant recipients. British Journal of Clinical Pharmacology, 60 (5), 560-565. doi: 10.1111/j.1365-2125.2005.02473.x |
|
2005 Journal Article Population pharmacokinetics and association between A77 1726 plasma concentrations and disease activity measures following administration of leflunomide to people with rheumatoid arthritisChan, V., Charles, B. G. and Tett, S. E. (2005). Population pharmacokinetics and association between A77 1726 plasma concentrations and disease activity measures following administration of leflunomide to people with rheumatoid arthritis. British Journal of Clinical Pharmacology, 60 (3), 257-264. doi: 10.1111/j.1365-2125.2005.02415.x |
|
2005 Conference Publication Directions for pharmacy as we move forwardTett, S. E. (2005). Directions for pharmacy as we move forward. The Society of Hospital Pharmacists of Australia 27th Federal Conference, Brisbane, 10-13 Nov. 2005. Brisbane: Event Planners Australia. |
|
2005 Journal Article Empiric management of community-acquired pneumonia in Australian emergency departmentsMaxwell, D. J., McIntosh, K. A., Pulver, L. K., Easton, K. L., CAPTION Study Grp and Tett, S. E. (2005). Empiric management of community-acquired pneumonia in Australian emergency departments. Medical Journal of Australia, 183 (10), 520-524. doi: 10.5694/j.1326-5377.2005.tb07153.x |
|
2005 Other Outputs Rural community pharmacists integrating care for people with complex health needsNissen, L. M. and Tett, S. E. (2005). Rural community pharmacists integrating care for people with complex health needs. Brisbane: Pharmacy Guild of Australia. |
|
2005 Journal Article Impact of mycophenolate mofetil loading on drug exposure in the early posttransplant periodKiberd, B., Puthenparumpil, J. J., Fraser, A., Tett, S. E. and Lawen, J. (2005). Impact of mycophenolate mofetil loading on drug exposure in the early posttransplant period. Transplantation Proceedings, 37 (5), 2320-2323. doi: 10.1016/j.transproceed.2005.03.059 |
|
2005 Conference Publication Use of non-selective non-steroidal anti-inflammatory drugs (NSAID), COX-2 inhibitors (COX-2) and paracetamolBarozzi, N. and Tett, S.E. (2005). Use of non-selective non-steroidal anti-inflammatory drugs (NSAID), COX-2 inhibitors (COX-2) and paracetamol. Joint Meeting of ASCEPT and APSA, Melbourne, 4-7 Dec. 2005. Australia: Australasian Society of Clinical & Experimental Pharmacologists & Toxicologists. |
